CD44 and colorectal carcinoma: Thus, since we demonstrate that the variant CD44 isoform CD44v8–10 is selectively expressed in the colonic SCs, we predict that CD44v8–10 will be a more specific and better prognostic SC marker than pan-CD44 for CRC patient outcomes.